Dapagliflozin 10 mg + Metformin Hydrochloride 500 mg ER (Extended Release) Tablet is a combination oral anti-diabetic medicine used for the management of Type 2 Diabetes Mellitus. Dapagliflozin (SGLT2 inhibitor) lowers blood sugar by promoting glucose excretion through urine, while Metformin ER reduces hepatic glucose production and improves insulin sensitivity with prolonged, steady action.
